 HomeProductsKey IntermediatesCinacalcet Hydrochloride CAS 364782-34-3 / 226256-56-0

Contact Supplier

Ms. Caroline

Leave a message

Contact Now

You May Like

Valerophenone CAS 1009-14-9 Powder Liquid Contact Now

CAS 28578-16-7 Pmk Oil Pmk Powder Pmk Liquid Contact Now

Rich Stock BMK Oil Powder CAS 20320-59-6 Contact Now

Amino Acid Nutrition Supplements L-Glutamine CAS 56-85-9 Contact Now

Supplement Creatine Monohydrate Powder CAS 6020-87-7 Contact Now

Levamisole Hydrochloride HCl CAS 16595-80-5 Powder Contact Now

Phenibut CAS 1078-21-3 Fphenibut HCl Phenibut Contact Now

Nootropics Powder Phenibut for Fatigue Reduce CAS 1078-21-3 Contact Now

 

Cinacalcet Hydrochloride CAS 364782-34-3 / 226256-56-0

Name: Nefiracetam
Uploaded: 2022-12-18T16:30:47+08:00
Description: Cinacalcet hydrochloride is the only calcimimetic currently approved by the US FDA for use in humans. Its

$2 - 3 /Gram

100 /Gram (Min. Order)

option:

10 grams per vial/bag

Payment Type:

T/T,Paypal

Incoterm:

FOB

Min. Order:

100 Gram

Transportation:

Land,Air,Express,Ocean

Port:

Shanghai,Shenzhen,Guangzhou

Contact Now

 Chat Now

Product Description

Product Attributes
Supply Ability & Additional Information
Packaging & Delivery

< >

Overview

Product Attributes

Model No.: CINACALCET

Brand: Rhine

Grade: Phamaceutical Grade

Place Of Origin: China

Test Method: HPLC UV COA

Specification: 10g:vial/bag

Package: Bottles, foil bags

Trademark: RHINE

Sec-HPLC: 99.5%

Cas: 603139-19-1

Molecular Formula: C22H22F3N

MW: 357.42

Supply Ability & Additional Information

Packaging: Foil bag /bottle

Productivity: 10 kg per month

Transportation: Land,Air,Express,Ocean

Place of Origin: china

Supply Ability: 500 grams/month

Certificate: N/A

HS Code: 2934993000

Port: Shanghai,Shenzhen,Guangzhou

Payment Type: T/T,Paypal

Incoterm: FOB

Packaging & Delivery

Selling Units:: Gram

Package Type:: Foil bag /bottle

Cinacalcet hydrochloride is the only calcimimetic currently approved by the US FDA for use in humans. Its approved clinical indications include: treatment of secondary hyperparathyroidism in patients with chronic kidney disease on dialysis; hypercalcemia in patients with inoperable parathyroid cancer. Cinacalcet is the first drug in a new class of compounds known as calcimimetic agents that activate calcium receptors in the parathyroid gland, thereby reducing parathyroid hormone secretion....

Product Categories : Key Intermediates

Hot Products

Email to this supplier

*Subject:
*To:

Ms. Caroline
*Email:
*Message:

Your message must be between 20-8000 characters